article · Biomedical Journal of Scientific & Technical Research
Malaria in pregnancy is associated with adverse maternal and foetal outcomes especially in sub- Saharan Africa. Sulphadoxine Pyrimethamine (SP) is recommended for Intermittent Preventive Therapy (IPT) against malaria in pregnancy. However, resistance to SP has been linked to reduction in its effectiveness. WHO recommends uptake of SP at each Antenatal Care (ANC) visit at least four weeklies apart, but the effects of number of doses of SP on clearance of malaria parasitaemia and pregnancy outcome still require comprehensive review.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.26717/bjstr.2024.58.009147
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.